---
category: news
title: "Deargen Signs Agreement With Sookmyung Women’s University Research & Business Development Foundation for Licensing ‘NASH Biomarker’ Technologies"
excerpt: "Deargen (President: Kilsoo Kang), an artificial intelligence (AI)-powered drug discovery and development company, announced on July 27 that it signed an agreement with Sookmyung Women’s University Research & Business Development Foundation for licensing biomarker technologies for determining the progression stage of NASH (non-alcoholic steatohepatitis) patients."
publishedDateTime: 2021-07-27T12:02:00Z
originalUrl: "https://www.cadillacnews.com/ap/business/deargen-signs-agreement-with-sookmyung-women-s-university-research-business-development-foundation-for-licensing-nash/article_c7517cda-62b6-5852-9fdb-cb79935f2286.html"
webUrl: "https://www.cadillacnews.com/ap/business/deargen-signs-agreement-with-sookmyung-women-s-university-research-business-development-foundation-for-licensing-nash/article_c7517cda-62b6-5852-9fdb-cb79935f2286.html"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Cadillac Evening News
  domain: cadillacnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://bloximages.newyork1.vip.townnews.com/cadillacnews.com/content/tncms/assets/v3/editorial/9/9c/99cbdf74-f10f-5862-8632-2169689ed864/60fff9a210107.image.jpg?resize=1016%2C630"
    width: 1016
    height: 630
    isCached: true

secured: "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;bBNd2VtjV6JrQblMn7u45Q=="
---

